Rockefeller Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-24
| Closed | -$1K | – | 2098 |
|
|
2022
Q4 | $1K | Buy |
24
+8
| +50% | +$333 | ﹤0.01% | 3638 |
|
|
2022
Q3 | $1K | Sell |
16
-112
| -88% | -$7K | ﹤0.01% | 3668 |
|
|
2022
Q2 | $11K | Buy |
128
+118
| +1,180% | +$10.1K | ﹤0.01% | 3051 |
|
|
2022
Q1 | $1K | Sell |
10
-19
| -66% | -$1.9K | ﹤0.01% | 3697 |
|
|
2021
Q4 | $3K | Buy |
+29
| New | +$3K | ﹤0.01% | 3407 |
|
|
2021
Q3 | – | Sell |
-50
| Closed | -$6K | – | 3687 |
|
|
2021
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 2955 |
|
|
2021
Q1 | $6K | Buy |
+50
| New | +$6K | ﹤0.01% | 2814 |
|
|
2020
Q2 | – | Sell |
-100
| Closed | -$11K | – | 2572 |
|
|
2020
Q1 | $11K | Hold |
100
| – | – | ﹤0.01% | 1706 |
|
|
2019
Q4 | $14K | Hold |
100
| – | – | ﹤0.01% | 1497 |
|
|
2019
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 1406 |
|
|
2019
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 1165 |
|
|
2019
Q1 | $12K | Buy |
+100
| New | +$12K | ﹤0.01% | 1421 |
|